Concepedia

Renata Sano

RS

Statistics

Publications

6

Citations

600

H-Index

6

Active since

2015

Affiliations

Children's Hospital of Philadelphia(Current)

University of Pennsylvania

Virginia Cancer Institute

Center for Cancer Research

Virginia Commonwealth University

Renata Sano is an author at Children's Hospital of Philadelphia specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2015–2021

6

Publications

6

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma

Nicole R. Infarinato, Jin H. Park, Kateryna Krytska et al. · Cancer Discovery · 2015 · 181 citations · Full text

, , +15

Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination

Jungoh Ham, Carlotta Costa, Renata Sano et al. · Cancer Cell · 2016 · 130 citations · Full text

, , +16

Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma

Kateryna Krytska, Hannah T. Ryles, Renata Sano et al. · Clinical Cancer Research · 2015 · 105 citations · Full text

, , +17

Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against Neuroblastoma

Andrew Wood, Kateryna Krytska, Hannah T. Ryles et al. · Clinical Cancer Research · 2016 · 97 citations · Full text

, , +17

An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma

Renata Sano, Kateryna Krytska, Colleen Larmour et al. · Science Translational Medicine · 2019 · 68 citations · Full text

, , +15

1–5 of 6